The health system hopes to pair the data with nearly three decades worth of electronic health records as well as medical histories provided by contributors.
23andMe has gotten the OK from the US Food and Drug Administration for its genetic health risk report on three mutations that increase breast cancer risk.
Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.
An NPR reporter finds that ancestry results from genetic testing don't always reflect family history.
A new report predicts a near tripling of the direct-to-consumer genetic testing market in about five years, according to HealthcareITNews.
New companies say they can use genetics to predict what a couple's child would be like, Wired reports.
American customers' interest in their genetic ancestry continues to be the primary driver of the consumer genomics market and shows no signs of diminishing.
Time magazine lists a few things recipients of genetic testing kit gifts should know.
Wired reports that AncestryDNA sold 1.5 million genetic testing kits this Black Friday.
A number of experts have questioned the clinical validity underlying Interleukin's tests and hope Orig3n will not revive them.
Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.
The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.
Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.
In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.